Maybe give them a little credit for the timing. When the drug gets approved, stock will fly high. This validates the entire ADC approach. A few million of decreased royalties is not going to hurt this company in the long run. It's just the short time attitudes of analysts (Hell if they cant calculate month to month EPS _ then they have no job security). If the drug had gotten approved and then the royalty news came out, the pain would have been a lot worse and more would be screaming for the heads of mgmt. The timing for this announcmeent was very smart!!!